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75-year-old man with lung cancer 
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-defibrillator — case report
ABSTRACT
We present a case of a 75-year-old man, who underwent a scheduled implantable cardioverter-defibril-
lator reoperation and has had a lung cancer found in a chest X-ray taken after the procedure, that was 
completely obscured by the previous device. 
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Introduction
Lung cancer is the most dominant form of cancer 
among men and the second one according to frequency 
among women in Poland [1]. In a group of implantable 
cardioverter-defibrillator (ICD) recipients, there are 
patients diagnosed with lung cancer but nationwide 
population-based cohort study in Denmark did not indi-
cate a causal relationship between ICD implantation and 
cancer occurrence [2]. The aim of this case report was 
to point out not to forget about lung area hidden under 
the cardiac implantable electronic devices (CIEDs), as in 
the presented case the tumor was completely obscured 
by the previous device in prior chest X-ray.
Case report
A 75-year-old patient with coronary artery disease, 
hypertension, chronic left ventricular heart failure (New 
York Heart Association [NYHA] class II) and intermit-
tent claudication was admitted to the Cardiology De-
partment of University Hospital no 1 in Bydgoszcz for 
upgrade from ICD to cardiac resynchronization therapy 
defibrillator (CRT-D) with concomitant transvenous lead 
extraction (TLE). 
The patient’s medical history included an episode 
of ventricular fibrillation on 14th October 2009, coronary 
artery disease with a critical stenosis of right coronary 
artery on coronary angiography with subsequent un-
successful, percutaneous coronary intervention. Echo-
cardiographic examination at that time showed normal 
left ventricular ejection fraction (LVEF 55%). Patient was 
qualified for ICD implantation for secondary prevention 
of sudden cardiac death. On 28th October 2009 a single 
chamber ICD (Biotronik Lumax 300 VR-T) was implanted 
with a single coil Saint Jude Medical Durata lead. De-
fibrillation threshold test was successful at 18 J. 
Between October 2009 and August 2015 the pa-
tient had multiple follow-up visits in the Outpatient 
Electrophysiology Clinic. In February 2012 the patient 
underwent electrical storm with multiple ICD discharges 
due to recurrent episodes of ventricular tachycardia and 
ventricular fibrillation. The only pathology identified as 
the cause was mild hypokalemia and the patient was 
started on amiodarone. Since September 2014 signs 
of electrode dysfunction were noted such as gradually 
growing ventricular pacing thresholds (from 1.2 V/1 ms 
in September 2014 up to 4.9 V/1 ms in July 2015) and in-
creasing low-voltage circuit impedance (from 498 Ohm 
in September 2014 up to 2550 Ohm in July 2015), 
with normal and stable coil impedance and sensing 
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values. In July 2015 ICD battery elective replacement 
indication (ERI) status was reached. Due to ERI, signs 
of dysfunction of the high voltage lead and presence 
of clinical indications for cardiac resynchronization 
therapy (progression of heart failure — NYHA class II 
on admission, with concomitant left ventricular systolic 
dysfunction (left ventricular ejection fraction [LVEF] of 
32%, and presence of left bundle branch block with 
QRS duration of 160 ms), the patient was qualified for 
replacement of the dysfunctional lead with concomitant 
upgrade from ICD to CRT-D.
The patient was admitted to the Cardiology Depart-
ment on 27th August 2015. On admission he reported 
only moderate exertional dyspnoe with no other 
significant symptoms. Physical examination revealed 
enlarged axillary lymph nodes on the left side and lack 
of pulse on the popliteal and dorsal arteries on both 
sides (the patient had a history of intermittent claudica-
tion and was under supervision of vascular surgeon). 
Chest X-ray taken on hospital admission showed no 
abnormalities. The echocardiographic parameters were 
as follows: left ventricular ejection fraction: 32%, left 
ventricular end-diastolic diameter: 62 mm, left atrium 
diameter: 44 mm, interventricular septum diameter: 
12mm. Low concentration of thyroid stimulating hor-
mone (TSH) and slightly increased thyroid hormones 
prompted diagnosis of hyperthyroidism, probably 
secondary to amiodarone therapy and thiamazolum 
was added to the chronic treatment. 
On 28th July 2015 the dysfunctional lead and the 
ICD can were successfully extracted and replaced 
with a  Boston Scientific Origen CRT-D device with 
Figure 1. The posteroanterior chest X-ray taken before 
TLE procedure
Figure 2. The posteroanterior chest X-ray taken after TLE 
procedure
a  Medtronic CapsureFix atrial lead, single coil Saint 
Jude Medical Durata high voltage lead and bipolar 
Saint Jude Medical Quickflex left ventricular lead. The 
surgery was uneventful.
As a routine post-procedural follow-up investigation, 
the standard posterior-anterior (PA) and lateral chest 
X-rays were taken (Figure 2. and 3.), which unex-
pectedly showed a round shape shadow in the upper 
pole of the left lung (area completely obscured by the 
previous device in pre-procedural X-ray — Figure 1.). 
Subsequent chest computed tomography revealed 
a pathological mass in the upper lobe of the left lung, 
sized 47x45x41 mm, with irregular, polycyclic borders, 
with contrast enhancement — suggestive for lung 
tumor. Abdominal ultrasound performed in search for 
possible metastatic foci showed no abnormalities. The 
patient was discharged from hospital and referred to 
a pulmonology department. 
Subsequent telephone follow-up with the pa-
tient’s  family member revealed that the patient was 
qualified only for palliative therapy and eventually pa-
tient died in September 2016 due to respiratory failure.
Timeline of events
2009.10 — ICD implantation for secondary prevention 
of sudden cardiac death.
2012.02 — Electrical storm only with mild hypokalemia 
identified as the only reversible cause. Amiodaron 
added to therapy.
2014.09 — First signs of high voltage lead dysfunction.
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cer, but the authors concluded that extended follow-up 
data are needed to elucidate risks for individual cancer 
types [2]. According to the literature, there have been 
cases of patients with CIEDs and lung cancer showing 
successful treatment of those patients with radiotherapy 
[3–4]. If radiotherapy is indicated or additional diagnos-
tics is needed (i.e. lung biopsy) and it’s not possible due 
to localization of CIED, there is always a possibility to 
relocate or remove the device. However, the radiotherapy 
is not the only possible treatment for lung cancer in the 
CIED recipients. In case of the interventional pulmonol-
ogy procedures consultation with a physician involved 
in the CIED implantation is always required. It is usually 
necessary to change the parameters of the device for 
the time of surgery in order to prevent adverse events 
and more frequent follow-up visits in the Outpatient 
Electrophysiology Clinic in the course of radiotherapy 
are warranted. 
The distinguishing feature of this case is an incidental 
diagnosis of lung cancer after relocation of the device 
during the exchange procedure. The pathological finding 
that was present prior to the surgery and could suggest 
a neoplasmatic process were the enlarged axillary lymph 
nodes. It was only the accidental change of the position 
of the device that allowed to visualize the previously 
invisible pulmonary field. In a case report presented by 
Bowers et al. two patients were also diagnosed with lung 
cancer directly posterior to a previously implanted ICD 
device, but in both cases, the new opacities were not 
completely overshadowed by the device [5]. One should 
be remembered that the field under the CIED may be not 
visible in the standard PA chest X-ray. This is important 
as the number of CIEDs recipient’s is increasing and lung 
cancer is one of the most frequent cancers.
Learning points
The area under the CIED cannot be seen in the standard 
PA chest X-ray and this should be kept in mind. In order 
to visualize this lung area, there is a need for an additional 
side chest X-ray or a computed tomography (CT) scan. 
In patients with CIEDs and symptoms suggestive of 
lung cancer, but normal results of the standard PA chest 
X-ray, extensive imaging methods should be applied. 
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